The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Complement C 3 Is a Risk Factor for the Development of Diabetes
Open accessAbstract
Cross-sectional studies have reported strong correlations between plasma levels of complement C3, insulin, and glucose. This prospective study explored whether elevated levels of C3, C4, and other inflammation-sensitive plasma proteins (ISPs; fibrinogen, orosomucoid, α1-antitrypsin, haptoglobin, and ceruloplasmin) are associated with the development of diabetes. Plasma proteins were measured in 2,815 nondiabetic healthy men, age 38–50 years, who were reexamined after a mean follow-up of 6.1 years. Diabetes development (n = 123) was studied in relation to baseline levels of plasma proteins. After adjusting for age, screening year, and glucose at baseline, the odds ratio (95% CI) for developing diabetes was 1.00, 2.4 (1.1–5.3), 2.9 (1.4–6.0), and 5.6 (2.8–10.9), respectively, for men with C3 in the 1st, 2nd, 3rd, and 4th quartiles (trend: P < 0.00001). Fibrinogen, haptoglobin, C4, and the number of elevated ISPs were also related to future diabetes in this model. Only C3 was significantly associated with diabetes development after further adjustments for potential confounders, including BMI, insulin, and other inflammatory markers. We concluded that the risk of developing diabetes is related to levels of complement C3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
The role of TNFα and TNF receptors in obesity and insulin resistance
Hotamisligil, G. S. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00490.x · Cited by 780
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534
Cited by
Traffic-Related Air Pollution and Incident Type 2 Diabetes: Results from the SALIA Cohort Study
Krämer, U., Herder, C., Sugiri, D., Strassburger, K., Schikowski, T., Ranft, U., & Rathmann, W. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901689 · Cited by 394
Samaras, K., Botelho, N. K., Chisholm, D. J., & Lord, R. V. (2010) · Obesity · doi:10.1038/oby.2009.443 · Cited by 287
King, B. C., Kulak, K., Krus, U., Rosberg, R., Golec, E., Wozniak, K., Gomez, M. F., Zhang, E., O'Connell, D. J., Renström, E., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.009 · Cited by 151
van Oostrom, A. J. H. H. M., Alipour, A., Plokker, T. W. M., Sniderman, A. D., & Cabezas, M. C. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.009 · Cited by 102
Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis
Segers, F. M., Verdam, F. J., de Jonge, C., Boonen, B., Driessen, A., Shiri-Sverdlov, R., Bouvy, N. D., Greve, J. W. M., Buurman, W. A., & Rensen, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110053 · Cited by 50
Metadata
- Authors
- Engström, G., Hedblad, B., Eriksson, K.-F., Janzon, L., & Lindgärde, F.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-02-01
- Volume
- 54
- Issue
- 2
- Pages
- 570-575
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2172092453
- Cited by
- 230
- References
- 4
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complement C 3 Is a Risk Factor for the Development of Diabetes. https://app.cochat.ai/papers/10.2337/diabetes.54.2.570
- The paper
- Engström, G., Hedblad, B., Eriksson, K.-F., Janzon, L., & Lindgärde, F. (2005). Complement C 3 Is a Risk Factor for the Development of Diabetes. Diabetes. https://doi.org/10.2337/diabetes.54.2.570
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.